LU78997A1 - Procede en vue de provoquer une tolerance immunologique - Google Patents

Procede en vue de provoquer une tolerance immunologique

Info

Publication number
LU78997A1
LU78997A1 LU78997A LU78997A LU78997A1 LU 78997 A1 LU78997 A1 LU 78997A1 LU 78997 A LU78997 A LU 78997A LU 78997 A LU78997 A LU 78997A LU 78997 A1 LU78997 A1 LU 78997A1
Authority
LU
Luxembourg
Prior art keywords
procedure
immunological tolerance
inducing immunological
inducing
tolerance
Prior art date
Application number
LU78997A
Other languages
English (en)
French (fr)
Original Assignee
Katz D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katz D filed Critical Katz D
Publication of LU78997A1 publication Critical patent/LU78997A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S524/90—Antigen-antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU78997A 1977-02-03 1978-02-03 Procede en vue de provoquer une tolerance immunologique LU78997A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/764,586 US4191668A (en) 1977-02-03 1977-02-03 Induction of immunological tolerance

Publications (1)

Publication Number Publication Date
LU78997A1 true LU78997A1 (fr) 1978-06-21

Family

ID=25071153

Family Applications (1)

Application Number Title Priority Date Filing Date
LU78997A LU78997A1 (fr) 1977-02-03 1978-02-03 Procede en vue de provoquer une tolerance immunologique

Country Status (17)

Country Link
US (1) US4191668A (xx)
JP (1) JPS53121943A (xx)
AU (1) AU515181B2 (xx)
BE (1) BE863656A (xx)
CA (1) CA1118347A (xx)
CH (1) CH644521A5 (xx)
DE (1) DE2804457C2 (xx)
DK (1) DK155174C (xx)
FI (1) FI780312A (xx)
FR (1) FR2379287A1 (xx)
GB (1) GB1599454A (xx)
LU (1) LU78997A1 (xx)
MX (1) MX6266E (xx)
NL (1) NL7801220A (xx)
NO (1) NO153419C (xx)
SE (1) SE464616B (xx)
ZA (1) ZA78613B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4276206A (en) * 1979-01-18 1981-06-30 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4253995A (en) * 1980-02-11 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
US4253996A (en) * 1980-02-13 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
DE3114362C2 (de) * 1980-04-11 1983-08-18 Toshiyuki Prof. Nara Hamaoka Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung
EP0077158A1 (en) * 1981-10-09 1983-04-20 Beecham Group Plc Modified allergens
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US6022544A (en) 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US4950469A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US5017648A (en) * 1986-05-30 1991-05-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
CA1309558C (en) * 1986-05-30 1992-10-27 Quidel D-gl conjugate therapy
US4950713A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US5552391A (en) * 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
US5162515A (en) * 1990-01-16 1992-11-10 La Jolla Pharmaceutical Company Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
US5391785A (en) * 1990-01-16 1995-02-21 La Jolla Pharmaceutial Company Intermediates for providing functional groups on the 5' end of oligonucleotides
CA2073846C (en) * 1991-07-15 2007-09-18 David S. Jones Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US8071737B2 (en) 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US5874409A (en) 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6399578B1 (en) 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US6458953B1 (en) 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US20030039659A1 (en) * 1999-09-24 2003-02-27 Mccormick Alison A. Self antigen vaccines for treating B cell lymphomas and other cancers
US7084256B2 (en) * 1999-09-24 2006-08-01 Large Scale Biology Corporation Self antigen vaccines for treating B cell lymphomas and other cancers
AU2001268228A1 (en) 2000-06-08 2001-12-17 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation
US3825525A (en) * 1969-08-06 1974-07-23 Beecham Group Ltd Allergens reacted with carbodiimides

Also Published As

Publication number Publication date
DK49178A (da) 1978-08-04
DK155174B (da) 1989-02-27
DK155174C (da) 1989-07-10
AU3293378A (en) 1979-08-09
GB1599454A (en) 1981-10-07
BE863656A (fr) 1978-05-29
DE2804457A1 (de) 1978-08-10
SE464616B (sv) 1991-05-27
MX6266E (es) 1985-02-27
CA1118347A (en) 1982-02-16
SE7801268L (sv) 1978-08-04
FR2379287B1 (xx) 1980-08-29
FR2379287A1 (fr) 1978-09-01
ZA78613B (en) 1978-12-27
DE2804457C2 (de) 1984-04-12
JPH0428689B2 (xx) 1992-05-15
NO153419B (no) 1985-12-09
JPS53121943A (en) 1978-10-24
NL7801220A (nl) 1978-08-07
FI780312A (fi) 1978-08-04
CH644521A5 (de) 1984-08-15
US4191668A (en) 1980-03-04
AU515181B2 (en) 1981-03-19
NO153419C (no) 1986-03-19
NO780366L (no) 1978-08-04

Similar Documents

Publication Publication Date Title
LU78997A1 (fr) Procede en vue de provoquer une tolerance immunologique
SE7803475L (sv) Hallare for pasar
SE7803476L (sv) Hallare for pasar
BE864856A (fr) Procede de determination immunologique
BE873136A (fr) Procede de preparation de la vincadifformine
FI780645A (fi) Foer industriellt bruk avsedd flaekt med under drift varierbar bladstigning
SE7805258L (sv) Stralkastare
SE7712754L (sv) Bervegg for rorslingor
AT364318B (de) Bauelementsystem
BE857244A (fr) Procede de preparation de 3-chlorocephalosporines
BE866490A (fr) Procede de dosage
BE866602A (fr) Arrangement de came
SE7812411L (sv) Instas for eldstad
FR2345454A1 (fr) Procede de preparation de 3-halomethylcephemes
BE860267R (fr) Procede de preparation de para-alkylphenols
ES244818Y (es) Dispositivo de fijacion auto-retenido
SE7807813L (sv) Platta for plattkondensor
BR7803504A (pt) Dispositivo para processamento de generos alimenticios
FI780216A (fi) Anordning foer faergtelevisionsmottagare
FR2342968A1 (fr) Procede de preparation de 3-desoxyanthocyanidines
RO71278A (ro) Procedeu pentru prelucrarea reziduurilor de distilare de la hidroformilarea propenei
BE868117A (fr) Procede de dimerisation
BE870104A (fr) Procede de preparation de 2-chlorosulfinyl-azetidin-4-ones
BE866904A (fr) Procede de preparation de 3-bromophtalide
BE850632R (fr) Procede de preparation de para-alkylphenols

Legal Events

Date Code Title Description
TP Transfer of rights

Free format text: 860903 SCRIPPS CLINIC & RESEARCH FOUNDATION LA JOLLA